Tocilizumab in COVID-19 Pneumonia (TOCIVID-19)
Clinical trial NCT04317092 · UNKNOWN
Trial details
- NCT number
- NCT04317092
- Sponsor
- National Cancer Institute, Naples
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-03-19
- Primary completion
- 2023-12-19
- Enrollment
- 402
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.